Find clinical trials for Asthma in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia

Chronic Obstructive Pulmonary Disease

Obstructive Lung Diseases

Allergic Rhinitis

Nasal Polyps

Rhinitis

Lung Diseases

Asthma trials near Montréal, QC, CAN:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling

Asthma

Drug: Placebo

Drug: Benralizumab

Phase 3

AstraZeneca

Montreal, Quebec, Canada and 83 other locations

A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma (ARTEMISIA)

compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...

Begins enrollment this month

Asthma

Drug: Placebo to AZD4604

Drug: AZD4604

Phase 2

AstraZeneca

Montreal, Quebec, Canada and 20 other locations

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma (HORIZON)

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling

Asthma

Biological: Tezepelumab

Other: Placebo

Phase 3

AstraZeneca

Montreal, Quebec, Canada and 100 other locations

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...

Enrolling

Asthma

Drug: BFF MDI 160/9.6 μg BID (320/19.2μg/day)

Drug: BD MDI 160 μg BID (320 μg/day)

Phase 3

AstraZeneca

Montreal, Quebec, Canada and 138 other locations

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE)

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Enrolling

Asthma

Biological: Placebo

Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)

Greenfield Park, Quebec, Canada and 429 other locations

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...

Enrolling

Asthma

Drug: BD MDI 320 μg

Drug: Open-label Symbicort TBH 320/9 μg

Phase 3

AstraZeneca

Montreal, Quebec, Canada and 181 other locations

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...

Enrolling

Asthma

Drug: Placebo

Drug: Dupilumab

Phase 4

Sanofi

Montreal, Quebec, Canada and 214 other locations

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

compared to omalizumab* To evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumab* To evaluate the safety of ...

Active, not recruiting

Asthma

Chronic Rhinosinusitis With Nasal Polyps

Drug: Omalizumab

Drug: Placebo

Phase 4

Sanofi

Montreal, Quebec, Canada and 94 other locations

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-1)

This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.

Active, not recruiting

Nasal Polyps

Drug: Placebo

Biological: Depemokimab (GSK3511294)

Phase 3

GlaxoSmithKline (GSK)

Montreal, Quebec, Canada and 105 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Asthma in .css-epvm6{white-space:nowrap;}Montréal, QC

Related conditions:

Asthma trials near Montréal, QC, CAN:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma (ARTEMISIA)

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma (HORIZON)

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NIMBLE)

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-1)

Find clinical trials for Asthma in Montréal, QC